Astellas Pharma Inc.

ALPMFOTCHealthcare● Active

$14.48

+$0.28(+1.99%)

Market Cap$25.9B

P/E Ratio—

52W High$17.85

52W Low$9.34

Avg Volume2K

Open$13.25

Beta0.07

Net Income Financials Revenue

Astellas Pharma Inc. (ALPMF) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

ALPMF · net income · updated Jun 8, 2026

Core profitability metrics

ALPMF · net income · margin · TTM · CAGR

Net income was $293.37B for FY2026 (fiscal year ending 2026-03-31), up 478.1% year-over-year. Net profit margin was 13.6%. Based on available data, Astellas Pharma Inc. has been profitable since at least 2012.

FY2026 Net Income$293.37B▲ +478.1% YoY

Trailing 12M (TTM)$293.07Btrailing 4 quarters sum

Net Profit Margin13.6%$293.37B ÷ $2.15T

YoY Change+478.1%—

5-Year CAGR+19.5%FY2020 → FY2026

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2012

▸ FMP /income-statement · Annual · ALPMF net income history · ALPMF profit margin

Annual net income data

ALPMF · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2026$293.37B▲ +478.1%13.6%$2.15T

FY2025$50.75B▲ +197.7%2.6%$1.91T

FY2024$17.05B▼ 82.7%1.1%$1.60T

FY2023$98.71B▼ 20.4%6.5%$1.52T

FY2022$124.09B▲ +2.9%9.6%$1.30T

Net income vs peers (Healthcare)

ALPMF vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Astellas Pharma Inc.YOU

ALPMF

$293.37B+478.1%13.6%

100%

Johnson & Johnson

JNJ

$26.80B+90.6%28.5%

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Astellas Pharma Inc. (ALPMF) reported net income of $293.37B for FY2026 (fiscal year ending 2026-03-31), up 478.1% year-over-year. The net profit margin was 13.6% — meaning the company kept $0.14 of every dollar of revenue as profit.

Based on available data, Astellas Pharma Inc. has been profitable since at least 2012. Net income reached a peak of $293.37B in FY2026. Data available for 15 fiscal years.

Astellas Pharma Inc.'s net profit margin was 13.6% for FY2026, based on the latest annual results.

Investors sometimes search for "Astellas Pharma Inc. net worth" — the company's market capitalization is a separate figure from ALPMF net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

ALPMF net income · 5 questions

Astellas Pharma Inc. is profitable. The company reported net income of $293.37B for FY2026, a net profit margin of 13.6%. Net income was up 478.1% year-over-year. Based on available data, Astellas Pharma Inc. has been profitable since at least 2012.

is ALPMF profitabledoes ALPMF make a profitALPMF profitabilityALPMF profitable company

▸ Source: FMP /income-statement · GAAP · Astellas Pharma Inc. · Astellas Pharma Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026